Where HCA Healthcare Stands With Analysts
HCA Healthcare (NYSE:HCA) has observed the following analyst ratings within the last quarter:
|Last 30 Days||1 Month Ago||2 Months Ago||3 Months Ago|
In the last 3 months, 12 analysts have offered 12-month price targets for HCA Healthcare. The company has an average price target of $215.17 with a high of $232.00 and a low of $190.00.
This current average has increased by 12.07% from the previous average price target of $192.0.
How Are Analyst Ratings Determined?
Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.
Analysts can recommend “buy”, “sell”, “hold”, or similar verbage for each stock based on that company’s recent performance. “Buy” indicates that an analyst is optimistic about a stock’s short-term or mid-term growth and is a recommendation to purchase the stock. On the other hand, “Sell” implies that an analyst forecasts a downwards trend for the stock. “Hold” suggests that investors should maintain their positions on that stock because of forecasted stagnation or lack of new information.
Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.
© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.